QQ客服 官方微博 反馈留言

	Development of 3-hydroxycinnamamide-based HDAC inhibitors with potent in vitro and in vivo anti-tumor activity
	Li, Xiaoyang; Hou, Jinning; Li, Xiaoguang; Jiang, Yuqi; Liu, Xueliang; Mu, Weiwei; Jin, Yiming; Zhang, Yingjie; Xu, Wenfang
刊名	EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
	2015
卷号	89页码:628-637
关键词	HDACs HDACIs Anti-tumor drugs Antiproliferative activity In vivo oral activity
DOI	10.1016/j.ejmech.2014.10.077
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4776319
专题	山东大学
作者单位	Shandong Univ, Sch Pharm
推荐引用方式 GB/T 7714	Li, Xiaoyang,Hou, Jinning,Li, Xiaoguang,et al. Development of 3-hydroxycinnamamide-based HDAC inhibitors with potent in vitro and in vivo anti-tumor activity[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,2015,89:628-637.
APA	Li, Xiaoyang.,Hou, Jinning.,Li, Xiaoguang.,Jiang, Yuqi.,Liu, Xueliang.,...&Xu, Wenfang.(2015).Development of 3-hydroxycinnamamide-based HDAC inhibitors with potent in vitro and in vivo anti-tumor activity.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,89,628-637.
MLA	Li, Xiaoyang,et al."Development of 3-hydroxycinnamamide-based HDAC inhibitors with potent in vitro and in vivo anti-tumor activity".EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 89(2015):628-637.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。